Jodie M Burton

Summary

Publications

  1. pmc A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
    J M Burton
    Division of Neurology, St Michael s Hospital, Toronto, Canada
    Neurology 74:1852-9. 2010
  2. doi request reprint Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
    Jodie M Burton
    Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
    Cochrane Database Syst Rev 12:CD006921. 2012
  3. pmc Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis
    Samantha Kimball
    Departments of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
    J Clin Endocrinol Metab 96:2826-34. 2011

Collaborators

Detail Information

Publications3

  1. pmc A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
    J M Burton
    Division of Neurology, St Michael s Hospital, Toronto, Canada
    Neurology 74:1852-9. 2010
    ..Our aim was to assess the tolerability of high-dose oral vitamin D and its impact on biochemical, immunologic, and clinical outcomes in patients with MS prospectively...
  2. doi request reprint Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
    Jodie M Burton
    Department of Clinical Neurosciences, University of Calgary, Calgary, Canada
    Cochrane Database Syst Rev 12:CD006921. 2012
    ..Oral steroids have been used in place of intravenous steroids, with lower direct and indirect costs...
  3. pmc Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis
    Samantha Kimball
    Departments of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
    J Clin Endocrinol Metab 96:2826-34. 2011
    ..The active metabolite of vitamin D, 1,25-dihydroxyvitamin D [1,25(OH)(2)D], is a potent modulator of immune cells in vitro...